Medication (generic)
Omeprazole
Starting dose
20 mg once daily before breakfast
Typical titration / target
Increase to 20 mg twice daily if needed
Monitoring / notes
Reassess after 4-8 weeks and step down when controlled.
Prescribing
PPI start
Initial dosing and step-down approach for gastroesophageal reflux.
Last reviewed 2026-01-05|gi | reflux | medication
Editorial feedback
Suggest an update
Flag outdated guidance or propose revised wording for this page. Do not include PHI or patient identifiers.
Jump to
Dosing quick reference
Medication (generic)
Pantoprazole
Starting dose
40 mg once daily before breakfast
Typical titration / target
Increase to 40 mg twice daily if needed
Monitoring / notes
Review for alarm symptoms or inadequate response.
| Medication (generic) | Starting dose | Typical titration / target | Monitoring / notes |
|---|---|---|---|
| Omeprazole | 20 mg once daily before breakfast | Increase to 20 mg twice daily if needed | Reassess after 4-8 weeks and step down when controlled. |
| Pantoprazole | 40 mg once daily before breakfast | Increase to 40 mg twice daily if needed | Review for alarm symptoms or inadequate response. |
Contraindications
- Avoid in known proton pump inhibitor hypersensitivity.
- Investigate alarm features before prolonged empiric therapy.
- Avoid indefinite continuation without a clear ongoing indication.
Renal and hepatic considerations
- In significant hepatic impairment, consider conservative dosing and closer review.
- Monitor for renal adverse-effect signals when treatment becomes prolonged.
- Reconcile drug-interaction risks before dose escalation.
Pregnancy and lactation cautions
- Confirm medication need and select pregnancy/lactation-compatible strategy.
- Use the lowest effective dose for the shortest necessary interval.
- Reassess ongoing need as clinical status changes.
Monitoring checkpoints
- Reassess response after 4-8 weeks and step down when controlled.
- Combine with lifestyle changes (weight loss, avoid late meals).
- Consider H. pylori testing if dyspepsia is prominent.
Stop or escalate criteria
- Step down or stop when symptom control is stable and no long-term indication remains.
- Escalate for dysphagia, bleeding, weight loss, progressive anemia, or persistent vomiting.
- Escalate if symptoms persist despite optimized adherence and timing.